Product Safety Recalls

Product Recall Tracker

EPINEPHRINE Recall D-1022-2022

Description: Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01

EPINEPHRINE Recall D-1022-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1022-2022
Event ID89646
BrandADRENALIN
Generic NameEPINEPHRINE
ManufacturerEPINEPHRINE
Original Package?1
Active SubstanceEPINEPHRINE
Drug RouteINTRAMUSCULAR
DistributionUSA nationwide.
Quantity58 cartons
Recall ReasoncGMP deviations: Temperature abuse
Drug ClassificationClass II
Drug Code Info20220615
Product NDC42023-159 42023-168
Product NUIN0000000209 N0000000245 N0000175552
Pharma Class (EPC)alpha-Adrenergic Agonist [EPC]
Pharma Class (CS)Catecholamines [CS]
Recall Initiation Date20220413
Report Date20220615
Classification Date20220609
Address9954 Maryland DriveDeep Run Iii Ste. 4000
Richmond, VA 23233
United States
Recalling FirmMckesson Medical-Surgical Inc. Corporate Office
Initial Notification Letter
Unique Ingredient IdentifierYKH834O4BH
Drug Application NumberNDA204200
Structured Product Labeling (SPL ID)79e5cb81-15ee-45f9-86c6-ece4bd8362d9
Structured Product Labeling (SPL Set ID)3b7a4364-668d-4eb2-a20c-04adc35aabe4
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.